Radiation-Induced Liver Injury: An Overview.

Area of Science:

• Oncology
• Radiation Oncology
• Hepatology

Background:

• Radiation therapy is a primary cancer treatment, with over 50% of patients utilizing it.
• Optimizing radiation therapy involves maximizing dose to tumors while minimizing exposure to surrounding normal tissues.
• Despite technological advancements in liver tumor radiotherapy, damage to normal liver tissue and Radiation-Induced Liver Disease (RILD) persist.

Purpose of the Study:

• To review the latest research findings on Radiation-Induced Liver Disease (RILD).
• To elucidate the underlying mechanisms of RILD.
• To identify future research directions for optimizing liver radiotherapy and mitigating RILD.

Main Methods:

• Literature review of recent research on RILD.
• Analysis of mechanisms contributing to radiation-induced liver damage.
• Discussion of current strategies and future research in liver radiotherapy.

Main Results:

• RILD remains a significant concern in liver tumor radiotherapy, impacting treatment efficacy.
• Understanding RILD mechanisms is crucial for developing protective strategies.
• Despite established tolerance doses, radiation damage to the liver occurs, affecting combined treatment modalities.

Conclusions:

• Further research into RILD mechanisms is essential for improving radiotherapy outcomes.
• Optimizing radiation delivery and exploring novel therapeutic approaches are key to reducing RILD.
• Addressing RILD is critical for the successful implementation of combined treatment strategies in liver cancer.